But expectations need to stay grounded
Mediators Inflamm 2016:3094642 Kristensen SL, Rrth R, Jhund PS, Docherty KF, Sattar N, Preiss D, Kber L, Petrie MC, McMurray JJV (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
in-vitro (made in the lab) data shows that it works, but is less effective than another vitamin C derivative, called MAP (that seems to be as effective as pure AA)
Pharmaceutical companies accept this is a possible side-effect of some GLP-1 medications for example it is mentioned in the patient leaflets of Wegovy but experts stress it is very rare
J Endocr Soc 5(9):bvab084
Some medications may require single-dose sterile water or other specific diluents